Hai cercato la traduzione di macrophage da Inglese a Maltese

macrophage activation
attivazzjoni tal-makrofagu

macrophage activation syndrome
sindrome tal-attivazzjoni tal-makrofagu

diagnosis of macrophage activation syndrome in sjia patients
dijanjosi tas-sindrome ta’ attivazzjoni tal-makrofagi f’pazjenti b’sjia

macrophage activation syndrome in patients with still’s disease
sindrome minn attivazzjoni makrofaġika f'pazjenti bil-marda ta’ still

efficacy for the treatment of macrophage activation syndrome has not been investigated.
l-effikaċja għall-kura tas-sindrome ta’ attivazzjoni tal-makrofagi ma ġietx investigata.

not known: macrophage activation syndrome*, worsening of symptoms of dermatomyositis
mhux magħrufa: sindrome ta’ l-attivazzjoni tal-makrofagu*, aggravar tas-sintomi ta’ dermatomijosite

there were 4 reports of macrophage activation syndrome in juvenile idiopathic arthritis clinical trials.
kien hemm 4 rapporti tas-sindrome tal-attivazzjoni tal-makrofagu fi provi kliniċi dwar l-artrite idjopatika taż-żgħażagħ.

enzymes-imiglucerase (recombinant macrophage targeted β - glucocerebrosidase), atc code:
enżimi- imiglucerase (β- glukocerebrosidase rikombinanta u mmirata lejn il- makrofagi), kodiċi atc:

systemic macrophage hypertrophy and hyperplasia occurred in rats and dogs, in many organ systems that normally contain macrophages.
kien hemm ipertrofija ta’ makrofaġi sistemika u iperplasja fil-firien u l-klieb, f’ħafna sistemi ta’ organi li ġeneralment ikun fihom makrofaġi.

macrophage activation syndrome (mas) is a serious life-threatening disorder that may develop in sjia patients.
sindrome tal-attivazzjoni tal-makrofagi (mas) huwa disturb serju ta’ periklu għall-ħajja li jista’ jiżviluppa f’pazjenti b’sjia.

331  not known: excessive activation of white blood cells associated with inflammation (macrophage activation syndrome).
• mhux magħrufa: attivazzjoni eċċessiva ta ’ ċelluli bojod tad- demm assoċjati ma ’ infjammazzjoni (sindrome ta ’ l- attivazzjoni tal- makrofagu).

haemophagocytic lymphohistiocytosis/macrophage activation syndrome (hlh/mas) has been uncommonly reported in the setting of crs.
il-limfoistjoċitożi emofagoċitika/sindrome ta’ attivazzjoni ta’ makrofaġi (hlh/mas - haemophagocytic lymphohistiocytosis/macrophage activation syndrome) kienet irrapportata b’mod mhux komuni f’każ ta’ crs.

if a child has a history of macrophage activation syndrome, (activation and uncontrolled proliferation of specific blood cells), tell your doctor.
jekk tifel jew tifla ikollu passat ta’ sindrome ta’ attivazzjoni tal-makrofagi, (attivazzjoni u proliferazzjoni mhux ikkontrollata ta’ ċelluli speċifiċi tad-demm), għid lit-tabib tiegħek.

also, it has been demonstrated in vitro that high-dose nsaids (cyclooxygenase inhibitors) can block the macrophage activating effect of liposomal mifamurtide.
ukoll, intwera in vitro li nsaids (inibituri taċ-ċikloossiġenażi) f’doża għolja jistgħu jimblokkaw l-effett li jattiva l-makrofaġi ta’ mifamurtide lipożomali.

imiglucerase (recombinant macrophage targeted acid ß-glucosidase) replaces the deficient enzyme activity, hydrolysing glucosylceramide, thus correcting initial pathophysiology and preventing secondary pathology.
imiglucerase (makrofagu rikombinanti targeted acid ß-glucosidase) jissostitwixxi l-attività tal- enzima defiċjenti, jagħmel hydrolysing ta’ glucosylceramide, u għaldaqstant jikkoreġi l- patofiżjoloġija inizjali u jimpedixxi patoloġija sekondarja.

phospholipidosis in pulmonary macrophages due to accumulation of memantine in lysosomes was observed in rodents.
fosfolipidożi f’makrofaġi fil-pulmun minħabba l-akkumulazzjoni ta’ memantine f’lisożomi ġiet osservata f’annimali ġerriema.